Abstract
The goal of this study was to identify genes whose mRNA levels are differentially expressed in human cells with acquired cisplatin (cDDP) resistance. Using the parental UMSCC10b head and neck carcinoma cell line and the 5.9-fold cDDP-resistant subline, UMSCC10b/Pt-S15, two suppressive subtraction hybridization (SSH) cDNA libraries were prepared. One library represented mRNAs whose levels were increased in the cDDP resistant variant (the UP library), the other one represented mRNAs whose levels were decreased in the resistant cells (the DOWN library). Arrays constructed with inserts recovered from these libraries were hybridized with SSH products to identify truly differentially expressed elements. A total of 51 cDNA fragments present in the UP library and 16 in the DOWN library met the criteria established for differential expression. The sequences of 87% of these cDNA fragments were identified in Genbank. Among the mRNAs in the UP library that were frequently isolated and that showed high levels of differential expression were cytochrome oxidase I, ribosomal protein 28S, elongation factor 1α, α-enolase, stathmin, and HSP70. The approach taken in this study permitted identification of many genes never before linked to the cDDP-resistant phenotype. © 2000 Cancer Research Campaign
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Alaoui-Jamali MA, Paterson J, Moustafa AE and Yen L (1997) The role of ErbB-2 tyrosine kinase receptor in cellular intrinsic chemoresistance: mechanisms and implications. Biochem Cell Biol 75: 315–325
Andrews PA and Albright KD (1992) Mitochondrial defects in cis-diamminedichloroplatinum(II) resistance in human ovarian carcinoma cells. Cancer Res 52: 1895–1901
Ara G, Kusomota T, Korbut TT, Cullere-Luengo F and Teicher BA (1994) Cis-diamminedichloroplatinum(II) resistant human tumor cell lines are collaterally sensitive to PtCl4(Rh-123)2: evidence for mitochondrial involvement. Cancer Res 54: 1497–1502
Chao A (1987) Estimating the population size for capture-recapture data with unequal catchability. Biometrics 43: 783–791
Chatterjee D, Liu CJ, Northey D and Teicher BA (1995) Molecular characterization of the in vivo alkylating agent resistant murine EMT-6 mammary carcinoma tumors. Cancer Chemother Pharmacol 35: 423–431
Chomczymski P and Sacchi N (1987) Single step method of RNA isolation by acid guanidium phenol-chloroform extraction. Anal Biochem 162: 156–159
Diatchenko L, Lau YFC, Campbell AP, Chenchik A, Moqadam F, Huang B, Lukyanov S, Lukyanov K, Gurskaya N, Sverdlov ED and Siebert PD (1996) Suppression subtractive hybridization: a method for generating differentially regulated tissue-specific cDNA probes and libraries. Proc Natl Acad Sci USA 93: 6025–6030
Fink D, Nebel S, Aebi S, Zheng H, Cenni B, Nehme A, Christen RD and Howell SB (1996) The role of DNA mismatch repair in drug resistance. Cancer Res 56: 4881–4886
Green DR and Reed JC (1998) Mitochondria and apoptosis. Science 281: 1309–1321
Hedrick SM, Cohen DI, Nielsen EA and Davis MM (1984) Isolation of cDNA clones encoding T cell-specific membrane-associated proteins. Nature 308: 149–153
Hubank M and Schatz DG (1994) Identifying differences in mRNA expression by representational difference analysis of cDNA. Nucleic Acids Res 22: 5640–5648
Krause CJ, Carey TE, Ott RW, Hurbis C, McClatchey KD and Regezi JA (1981) Human squamous cell carcinoma: establishment and characterization of new permanent cell lines. Arch Otolaryngol 107: 703–710
Kuang WW, Thompson DA, Hoch RV and Weigel RJ (1998) Differential screening and suppression subtractive hybridization identified genes differentially expressed in an estrogen receptor positive breast carcinoma cell line. Nucleic Acids Res 26: 1116–1123
Los G and Muggia FM (1994) Platinum resistance; experimental and clinical status. Hematol Oncol Clin North America 8: 411–429
Marth C, Widschwendter M, Kaern J, Jürgensen NP, Windbichler G, Zeimet AG, Trope C and Daxenbichler G (1997) Cisplatin resistance is associated with reduced interferon-gamma-sensitivity and increased HER-2 expression in cultured ovarian carcinoma cells. Br J Cancer 76: 1328–1332
Miyake H, Hanada N, Nakamura H, Kagawa S, Fujiwara T, Hara I, Eto H, Gohji K, Arakawa S, Kamidono S and Saya H (1998) Overexpression of Bcl-s in bladder cancer cells inhibit apoptosis induced by cisplatin and adenviral-mediated p53 gene transfer. Oncogene 16: 933–943
Nakata B, Barton RM, Robbins KT, Howell SB and Los G (1994) Association between hsp60 mRNA levels and cisplatin resistance in human head and neck cancer cell lines. Int J Oncology 5: 1425–1432
Schummer M, Ng W, Nelson P, Bumgarner R and Hood L (1997) Inexpensive handheld device for the construction of high-density nucleic acid arrays. Biotechniques 23: 1087–1092
Tedder TF, Streuli M, Schlossman SF and Saito H (1988) Isolation and structure of a cDNA encoding the B1 (CD20) cell-surface antigen of human B lymphocytes. Proc Nat Acad Sci USA 85: 208–212
Velculescu VE, Zhang L, Vogelstein B and Kinzler KW (1995) Serial analysis of gene expression. Science 270: 484–487
Yamada-Okabe T, Yamada-Okabe H, Kashima Y and Doi R (1995) Effects of oncogenes on the resistance to cis-diamminedichloroplatinum II and metallothionein gene expression. Toxicol Appl Pharmacol 133: 233–238
Yang GP, Ross DT, Kuang WW, Brown PO and Weigel RJ (1999) Combining SSH and cDNA microarrays for rapid identification of differentially expresses genes. Nucleic Acids Res 27: 1517–1523
Zhang L, Zhou W, Velculescu VE, Kern SE, Hruban RH, Hamilton SR, Vogelstein B and Kinzler KW (1997) Gene expression profiles in normal and cancer cells. Science 276: 1268–1272
Zhou W, Sokoll L, Bruzek DJ, Zhang L, Velculescu VE, Goldin SB, Hruban RH, Kern SE, Hamilton SR, Chan DW, Vogelstein B and Kinzler KW (1998) Identifying markers for pancreatic cancer by gene expression analysis. Cancer Epidemiol Biomarkers Prev 7: 109–112
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Johnsson, A., Zeelenberg, I., Min, Y. et al. Identification of genes differentially expressed in association with acquired cisplatin resistance. Br J Cancer 83, 1047–1054 (2000). https://doi.org/10.1054/bjoc.2000.1420
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1054/bjoc.2000.1420
Keywords
This article is cited by
-
HNF4A-AS1-encoded small peptide promotes self-renewal and aggressiveness of neuroblastoma stem cells via eEF1A1-repressed SMAD4 transactivation
Oncogene (2022)
-
RAD001 can reverse drug resistance of SGC7901/DDP cells
Tumor Biology (2014)
-
Identification of a Novel Binding Protein of FAT10: Eukaryotic Translation Elongation Factor 1A1
Digestive Diseases and Sciences (2012)
-
Identification and characteristics of a novel gene, EJO1, in the Chinese mitten crab (Eriocheir japonica sinensis) ovary
Molecular Biology Reports (2010)
-
Altered levels and regulation of stathmin in paclitaxel-resistant ovarian cancer cells
Oncogene (2003)